Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bath & Body Works Inc (BBWI) vs Charles Schwab Corporation Common Stock (SCHW) Price & Performance

Bath & Body Works IncTrade
Charles Schwab Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Bath & Body Works Inc vs Charles Schwab Corporation Common Stock — how do they compare? Bath & Body Works Inc trades at $20.64 (market cap $4.04B), while Charles Schwab Corporation Common Stock trades at $103 (market cap $175.83B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 43.5× Bath & Body Works Inc's market cap, and Bath & Body Works Inc pays the higher dividend (3.99%). Which is the better fit depends on your goals.

BBWISCHW
Market Cap
$4.04B$175.83B
Sector
Consumer CyclicalFinancials
52-Week High
$33.11$107.21
52-Week Low
$14.85$85.35
Enterprise Value
$7.93B
Dividend Yield
3.99%1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bath & Body Works Inc

BBWI trades at $20.42, up 0.44% today, with a bearish technical signal but attractive valuation metrics including a P/E of 5.8 and P/S of 0.58. Recent earnings show mixed quarterly beats, with Q1 2026 exceeding expectations. The company maintains solid profitability with a 10.03% net income margin and positive cash flow trends projected for 2026. Strategic initiatives include a new Ulta Beauty partnership and international expansion to drive growth amid declining revenue trends.

Outlook: BBWI presents a value opportunity with deep valuation discounts and operational strengths, though persistent revenue declines and high debt pose risks. Analyst consensus is cautiously optimistic with a $22 price target, suggesting modest upside potential if turnaround efforts gain traction against competitive and macroeconomic headwinds.

Charles Schwab Corporation Common Stock

Charles Schwab (SCHW) trades at $102.38, down 0.72% on the day, with a bullish technical outlook and strong fundamentals. Recent earnings beats, including Q1 2026 EPS of $1.43 versus $1.40 expected, highlight robust profitability. The stock is supported by a 21.79% ROE and a net income margin of 37.99%, with revenue growth to $23.92 billion in 2025. Positive sentiment is fueled by a Zacks Strong Buy upgrade and a consensus price target of $122.71, suggesting 20% upside.

Outlook remains favorable given earnings momentum and retail trading growth, but risks include interest rate sensitivity and competitive pressures. Analyst consensus is 58% buy, with institutional confidence bolstered by a recent dividend payment. The stock's valuation at a P/E of 20.35 appears reasonable relative to growth, though high RSI levels indicate potential near-term consolidation.

Returns comparison

Trailing returns across standard periods

About Bath & Body Works Inc

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.

Read more on BBWI

About Charles Schwab Corporation Common Stock

Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.

Read more on SCHW